Fluorocyclopentenylcytosine
- Generic Name
- Fluorocyclopentenylcytosine
- Drug Type
- Small Molecule
- Chemical Formula
- C10H12FN3O4
- CAS Number
- 865838-26-2
- Unique Ingredient Identifier
- 0Z4A82I0JO
- Background
Fluorocyclopentenylcytosine is under investigation in clinical trial NCT03189914 (RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer).
RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer
- First Posted Date
- 2017-06-16
- Last Posted Date
- 2023-12-06
- Lead Sponsor
- Processa Pharmaceuticals
- Target Recruit Count
- 46
- Registration Number
- NCT03189914
- Locations
- 🇺🇸
Rexahn Site, Milwaukee, Wisconsin, United States
Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies
- First Posted Date
- 2014-01-08
- Last Posted Date
- 2023-12-06
- Lead Sponsor
- Processa Pharmaceuticals
- Target Recruit Count
- 127
- Registration Number
- NCT02030067
- Locations
- 🇺🇸
Rexahn Site, Fairfax, Virginia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath